Evidence map›Paper›PMID 41576003›Full record

ArticlePloS one2026

Shared autonomic phenotype of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.

Peter Novak, David M Systrom, Alexandra Witte, Sadie P Marciano, Donna Felsenstein, Jeff M Milunsky, Aubrey Milunsky, Joel Krier, Mark C Fishman

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Letter to the Editor.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Peter NovakDepartment of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-5971-1208
David M SystromHarvard University, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-9610-6330
Alexandra WitteDepartment of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Sadie P MarcianoDepartment of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Donna FelsensteinHarvard University, Boston, Massachusetts, United States of America.
Jeff M MilunskyCenter for Genetics, Cambridge, Massachusetts, United States of America.
Aubrey MilunskyCenter for Genetics, Cambridge, Massachusetts, United States of America.
Joel KrierAtrius Health, Boston, Massachusetts, United States of America.
Mark C FishmanHarvard University, Boston, Massachusetts, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLong COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are relatively common and disabling multisystem disorders that share overlapping features, including post-infectious onset and similar clinical manifestations such as brain fog, fatigue, muscle pain, and dysautonomia with orthostatic intolerance. These similarities suggest that Long COVID and ME/CFS may share common pathophysiological mechanisms, though the underlying mechanisms remain poorly understood, partly due to the difficulty in quantifying many of the symptoms. MATERIALS AND

methodsThis retrospective study evaluated Long COVID and pre-COVID ME/CFS patients who completed autonomic testing between 2018 and 2023 at the Brigham and Women's Faulkner Hospital Autonomic Laboratory. The evaluations included autonomic tests (Valsalva maneuver, deep breathing, tilt-table test, and sudomotor function) with capnography and transcranial Doppler monitoring of cerebral blood flow velocity (CBFv) in the middle cerebral artery, neuropathic assessment through skin biopsies for small fiber neuropathy (SFN), invasive cardiopulmonary exercise testing (ICPET), and laboratory analyses covering metabolic, inflammatory, autoimmune, and hormonal profiles.

resultsA total of 143 Long COVID and 170 ME/CFS patients were analyzed and compared to 73 healthy controls and 290 patients with hypermobile Ehlers-Danlos syndrome (hEDS). Tests revealed extensive similarities between Long COVID and ME/CFS, including reduced orthostatic CBFv (92%/88% in Long COVID/ME/CFS), mild-to-moderate widespread autonomic failure (95%/89%), presence of SFN (67%/53%), postural tachycardia syndrome (POTS) (22%/19%), neurogenic orthostatic hypotension (15%/15%) and preload failure (96%/92%, assessed in 25/66 Long COVID/ME/CFS). Patients with hEDS exhibited more severe peripheral neurodegeneration compared to the other groups. Laboratory tests did not distinguish between the conditions.

conclusionBoth Long COVID and ME/CFS demonstrate dysregulation in cerebrovascular blood flow, autonomic reflexes, and small fiber neuropathy, suggesting that these conditions may share a common underlying pathophysiology. However, differing distributions of findings in patients with hEDS raise the question of whether these conditions represent distinct but overlapping syndromes or reflect a shared underlying pathway. Further research is required to clarify the relationship between these conditions and the potential underlying pathophysiological mechanisms.

Indexed as

Autonomic Nervous SystemCOVID-19Fatigue Syndrome, ChronicAdultFemaleHumansMaleMiddle AgedPhenotypePost-Acute COVID-19 SyndromeRetrospective StudiesSARS-CoV-2Small Fiber Neuropathy

Identifiers

PMID41576003
PMCPMC12829881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.